 |
China will soon become the world's 3rd largest market for pharmaceutical products, while China 's low cost base and abundant talent have the potential to disrupt the traditional supply chain. Few have approached strategically what China represents for the global pharmaceutical industry. Three prominent young business leaders in China founded NovaMed in 2006 to build a new kind of pharmaceutical company which would leverage China 's unique advantages and growing trends of globalization.
To read more, click here |
|
|
|
|
|
